Postgraduate Course at DDW: Complete Clinical Updates for Today's Practice | May 2025-INPATIENT MANAGEMENT OF ASUC, SEVERE CROHN'S DISEASE

Video Transcription

Video Summary

During a luncheon session, Dr. Bincy Abraham and Dr. Manpreet Kaur presented on managing hospitalized inflammatory bowel disease (IBD) patients, with a focus on severe Crohn's disease and acute severe ulcerative colitis. Dr. Abraham emphasized the importance of multidisciplinary care, advising against the premature use of steroids in Crohn's patients, as they can hinder healing in cases of abscesses or fistulas. Instead, she recommended thorough assessments to rule out infections and complications, and advised using steroids judiciously to manage obstructions, if needed. Nutritional support is crucial, and patients shouldn't be kept NPO unnecessarily. Monitoring for VTE and using anticoagulant prophylaxis in IBD flares is vital, as these patients are at increased risk. For surgical management, Dr. Abraham highlighted the importance of optimizing patients’ nutritional status, discussing the negative impact of pre-operative anemia and low albumin on surgical outcomes. <br /><br />Dr. Kaur focused on acute severe ulcerative colitis, stressing early endoscopic assessment and the need for pharmacological DVT prophylaxis. She discussed the importance of not delaying corticosteroid treatment while awaiting C. diff results, emphasizing simultaneous management of infections. She highlighted the potential roles of biologics like infliximab and JAK inhibitors in patients unresponsive to steroids, and underscored the importance of early surgical consultation for better outcomes. Both speakers emphasized individualized care planning and the proactive management of complications to improve patient outcomes.

Keywords

inflammatory bowel disease

Crohn's disease

ulcerative colitis

multidisciplinary care

steroids

nutritional support

anticoagulant prophylaxis

endoscopic assessment

biologics

individualized care